Trials / Sponsors / Immutep Australia Pty. Ltd.
Immutep Australia Pty. Ltd.
Industry · 1 registered clinical trial.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Completed | Phase 1 Study of IMP321 (Eftilagimod Alpha) Adjuvant to Anti-PD-1 Therapy in Unresectable or Metastatic Melano Stage IV Melanoma, Stage III Melanoma | Phase 1 | 2016-04-01 |